Modeling of Tumor Growth Incorporating the Effects of Necrosis and the Effect of Bevacizumab

Figure 3

The simulated inhibitor serum using the model with parameters resulting after identification for (a) Therapy 1 and for (b) Therapy 2.

(a)

(b)